| Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat A Serafín, J Roselló-Catafau, N Prats, C Xaus, E Gelpí, C Peralta The American journal of pathology 161 (2), 587-601, 2002 | 257 | 2002 |
| Adenosine monophosphate [ndash] activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat C Peralta, A Serafin, C Bl, M Guzm, N Prats, C Xaus, B Cutillas, E Gelp, ... Hepatology 34 (6), 1164-1173, 2001 | 230 | 2001 |
| Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function C McDermott-Roe, J Ye, R Ahmed, XM Sun, A Serafín, J Ware, L Bottolo, ... Nature 478 (7367), 114-118, 2011 | 173 | 2011 |
| Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease J Valles‐Ortega, J Duran, M Garcia‐Rocha, C Bosch, I Saez, L Pujadas, ... EMBO molecular medicine 3 (11), 667-681, 2011 | 132 | 2011 |
| Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion A Serafín, J Roselló‐Catafau, N Prats, E Gelpí, J Rodés, C Peralta Hepatology 39 (3), 688-698, 2004 | 131 | 2004 |
| Is ischemic preconditioning a useful strategy in steatotic liver transplantation? L Fernández, E Carrasco-Chaumel, A Serafín, C Xaus, L Grande, ... American Journal of Transplantation 4 (6), 888-899, 2004 | 92 | 2004 |
| Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis M García, A Pujol, A Ruzo, E Riu, J Ruberte, A Arbós, A Serafín, B Albella, ... PLoS genetics 5 (8), e1000615, 2009 | 75 | 2009 |
| Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers M Massip-Salcedo, A Casillas-Ramirez, R Franco-Gou, R Bartrons, ... The American journal of pathology 168 (5), 1474-1485, 2006 | 66 | 2006 |
| Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury C Peralta, A Serafin, L Fernandez-Zabalegui, ZY Wu, J Rosello-Catafau Transplantation proceedings 35 (5), 1800-1802, 2003 | 64 | 2003 |
| Ischemic preconditioning: tolerance to hepatic ischemia-reperfusion injury A Serafin, L Fernandez-Zabalegui, N Prat, ZY Wu, J Roselló-Catafau, ... Histology and histopathology, 2004 | 63 | 2004 |
| Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury A Casillas-Ramirez, M Amine-Zaouali, M Massip-Salcedo, ... Critical care medicine 36 (4), 1256-1266, 2008 | 60 | 2008 |
| New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury R Franco‐Gou, IB Mosbah, A Serafin, HB Abdennebi, J Roselló‐Catafau, ... Journal of gastroenterology and hepatology 22 (7), 1120-1126, 2007 | 59 | 2007 |
| Protection of reduced-size liver for transplantation R Franco-Gou, C Peralta, M Massip-Salcedo, C Xaus, A Serafín, ... American Journal of Transplantation 4 (9), 1408-1420, 2004 | 59 | 2004 |
| Executioner caspase-3 and 7 deficiency reduces myocyte number in the developing mouse heart M Cardona, JA López, A Serafin, A Rongvaux, J Inserte, D Garcia-Dorado, ... PLoS One 10 (6), e0131411, 2015 | 53 | 2015 |
| Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion? FS Ramalho, I Alfany-Fernandez, A Casillas-Ramirez, M Massip-Salcedo, ... Journal of Pharmacology and Experimental Therapeutics 329 (1), 130-140, 2009 | 52 | 2009 |
| Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation1 L Fernandez, N Heredia, C Peralta, C Xaus, J Rosello-Catafau, A Rimola, ... Transplantation 76 (2), 282-289, 2003 | 48 | 2003 |
| Trimetazidine: is it a promising drug for use in steatotic grafts? IB Mosbah, A Casillas-Ramírez, C Xaus, A Serafín, J Roselló-Catafau, ... World journal of gastroenterology: WJG 12 (6), 908, 2006 | 45 | 2006 |
| Immunohistochemical approach to the pathogenesis of bovine spongiform encephalopathy in its early stages E Vidal, M Márquez, R Tortosa, C Costa, A Serafín, M Pumarola Journal of virological methods 134 (1-2), 15-29, 2006 | 39 | 2006 |
| Therapeutic Targets in Liver Transplantation: Angiotensin II in Nonsteatotic Grafts and Angiotensin-(1—7) in Steatotic Grafts I Alfany-Fernández, A Casillas-Ramirez, M Bintanel-Morcillo, ... American Journal of Transplantation 9 (3), 439-451, 2009 | 35 | 2009 |
| Silent information regulator 1 protects the liver against ischemia–reperfusion injury: implications in steatotic liver ischemic preconditioning E Pantazi, MA Zaouali, M Bejaoui, A Serafin, E Folch‐Puy, V Petegnief, ... Transplant International 27 (5), 493-503, 2014 | 34 | 2014 |
